Viewing StudyNCT06484868



Ignite Creation Date: 2024-07-17 @ 12:02 PM
Last Modification Date: 2024-10-26 @ 3:33 PM
Study NCT ID: NCT06484868
Status: RECRUITING
Last Update Posted: 2024-07-03
First Post: 2024-06-26

Brief Title: Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
Sponsor:
Organization: Amryt Pharma

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 12
Enrollment Type: ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE4
Observational Models:
Time Perspective List:
Who Masked List: